RECRUITINGOBSERVATIONAL
Lower Urinary Tract Symptoms After Intravesical Therapy
Lower Urinary Tract Symptoms After Intravesical Therapy With Mitomycin C or BCG in Patients With Carcinoma of the Bladder
About This Trial
With this prospective, observational study, we would like to investigate the effect of instillation therapy using BCG or mitomycin C on short- and long-term irritative and obstructive lower urinary tract symptoms using validated questionnaires. The study will objectify the lower urinary tract symptoms and thereby provide better recommendations for therapy with mitomycin C or BCG.
Who May Be Eligible (Plain English)
Who May Qualify:
- Urinary bladder carcinoma requiring instillation therapy
- Complete resection of the tumor
- No intravesical chemotherapy in the last 3 months
Who Should NOT Join This Trial:
- Patients who are unable to complete the questionnaires
- Patients who are not willing to participate
- Patients with contraindications for instillation therapy (allergic reactions, immunosuppression)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Urinary bladder carcinoma requiring instillation therapy
* Complete resection of the tumor
* No intravesical chemotherapy in the last 3 months
Exclusion Criteria:
* Patients who are unable to complete the questionnaires
* Patients who are not willing to participate
* Patients with contraindications for instillation therapy (allergic reactions, immunosuppression)
Treatments Being Tested
OTHER
Validated questionnaires
BPIC-SS, ICIQ-OABqol, IIEF-EF oder FSFI, ICIQ-MLUTS oder ICIQ-FLUTS
Locations (1)
Nikolaos Pyrgidis
Munich, Bavaria, Germany